Back
PT Bukit Asam Tbk Vs. Sarepta Therapeutics Industry Stock Comparison
Sell
47
TBNGY
PT Bukit Asam Tbk
Last Price:
$4.00
Seasonality Move:
-12.63%
Sell
48
SRPT
Sarepta Therapeutics
Last Price:
$74.08
Seasonality Move:
14.66%
Sell
47
PT Bukit Asam Tbk (TBNGY)
is a Sell
Is PT Bukit Asam Tbk a Buy, Sell or Hold?
-
The current PT Bukit Asam Tbk [TBNGY] share price is $4.00. The Score for TBNGY is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
-
TBNGY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
48
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics a Buy, Sell or Hold?
-
The current Sarepta Therapeutics [SRPT] share price is $74.10. The Score for SRPT is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
-
SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
TBNGY Stock Price Chart
What is PT Bukit Asam Tbk's stock price today?
-
The PT Bukit Asam Tbk share price today is $4.00The current trend is relatively stagnant and TBNGY is experiencing slight buying pressure.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $74.10Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing slight selling pressure.
TBNGY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.02 | Sell |
| Relative Strength Index (14 RSI): | 30.64 | Sell |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4 - 4) | Sell |
| Bollinger Bands (100): | (3.95 - 4.53) | Sell |
SRPT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -8.7 | Sell |
| Relative Strength Index (14 RSI): | 27.9 | Sell |
| Chaikin Money Flow: | -367389 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (88.59 - 111.17) | Sell |
| Bollinger Bands (100): | (103.29 - 127.87) | Sell |
TBNGY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4 | Sell |
| 20-day SMA: | 4 | Sell |
| 50-day SMA: | 4.08 | Sell |
| 200-day SMA: | 4.31 | Sell |
| 8-day EMA: | 4 | Sell |
| 20-day EMA: | 4.02 | Sell |
| 50-day EMA: | 4.08 | Sell |
| 200-day EMA: | 4.31 | Sell |
SRPT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 87.22 | Sell |
| 20-day SMA: | 97.87 | Sell |
| 50-day SMA: | 108.64 | Sell |
| 200-day SMA: | 125.16 | Sell |
| 8-day EMA: | 84.58 | Sell |
| 20-day EMA: | 94.74 | Sell |
| 50-day EMA: | 105.16 | Sell |
| 200-day EMA: | 118.38 | Sell |
PT Bukit Asam Tbk Earnings Growth & TBNGY Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $2.52 per share, a decrease next quarter of $0.64 per share, an increase this year of $5.33 per share, and an increase next year of $5.23 per share.
PT Bukit Asam Tbk Technical Analysis
| Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 07 | 11 | 12 | 13 | 14 | 17 | 18 | 19 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Sarepta Therapeutics Technical Analysis
| Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 07 | 11 | 12 | 13 | 14 | 17 | 18 | 19 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||